Quality issues are still the number one reason for drug shortages, and in an effort to address this, the U.S. Food and Drug Administration is debuting a quality management maturity (QMM) program intended to incentivize drugmakers to invest in quality measures.
New FDA program incentivizes drugmakers to invest in quality measures
